Editorial review
Educational content is reviewed for source quality, clinical boundaries, and readability. It is not medical advice; confirm care decisions with a licensed clinician.
What DEA Special Registration Means
The Drug Enforcement Administration (DEA) has not finalized a Special Registration pathway for telehealth prescribing of controlled substances, including ketamine, based on the agency's most recent public rulemaking actions in 2026. Instead, telehealth ketamine prescribing currently runs on a series of temporary DEA rules that extend pandemic-era flexibilities, not on the permanent special registration that Congress directed the agency to create back in 2018. If you're evaluating an online ketamine clinic, the practical question is which temporary flexibility a prescriber is relying on right now, because a finished special registration program does not yet exist.
Quick Answer
DEA Special Registration for telehealth is a permanent pathway Congress ordered the DEA to create in 2018 so clinicians could prescribe controlled substances like ketamine by telehealth without a prior in-person exam, under added safeguards. The DEA proposed draft rules in March 2023 but has not issued a final special registration rule since. Until it does, legitimate online ketamine prescribers rely on temporary DEA telehealth flexibilities that have been extended more than once since the COVID-19 public health emergency ended. Confirm the current expiration date before you rely on any telehealth ketamine prescription.
Why a Special Registration Exists at All
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (Public Law 110-425) generally requires a prescriber to complete at least one in-person medical evaluation before prescribing a controlled substance, with narrow exceptions such as DEA-registered hospitals, VA facilities, and declared public health emergencies. Ketamine is a Schedule III controlled substance under the federal Controlled Substances Act, so it falls directly inside this requirement.
The SUPPORT for Patients and Communities Act of 2018 (Public Law 115-271) directed the DEA to build a "special registration" that would let qualifying telehealth practitioners prescribe controlled substances without that in-person exam, under conditions the agency would set, such as added monitoring or state-level reporting. Congress gave the DEA roughly a year to write the rule. The deadline passed without a final regulation, and the COVID-19 public health emergency made the gap temporarily moot by triggering a separate set of emergency telehealth flexibilities.
Compare your options
Move from the guide into a side-by-side comparison when you are ready to evaluate tradeoffs.
Compare optionsWhere the Rule Stands in 2026
In March 2023, the DEA and the Substance Abuse and Mental Health Services Administration (SAMHSA) jointly proposed rules to govern telehealth prescribing of controlled substances once the COVID-19 public health emergency flexibilities were set to expire. That proposal drew an unusually large volume of public comments, and rather than finalize it, the DEA's Diversion Control Division has repeatedly issued short-term extensions of the existing COVID-era flexibilities, each with its own expiration date pushed further back.
The most recent extension we reviewed kept these flexibilities in place through December 31, 2025. Whether the DEA issued a further extension, finalized a special registration rule, or let the flexibility lapse after that date is something you should verify directly, since this is an active rulemaking area. See our dedicated page on DEA telehealth flexibility expiration 2026 ketamine for the current status before you act on anything here.
Flexibility Dates Can Move Again
DEA telehealth flexibilities have been extended more than once since 2023, and the agency has not committed to a permanent special registration rule. Check the current expiration date and read our DEA telehealth flexibility expiration 2026 ketamine page before assuming any online prescription arrangement will continue uninterrupted.
Ketamine vs. Esketamine Under These Rules
Generic ketamine prescribed for depression, anxiety, or other off-label uses is covered by the flexibility described above, because it is a Schedule III controlled substance prescribed outside an FDA-approved indication. No form of ketamine itself carries full FDA approval for a mental health condition. Esketamine (brand name Spravato) is the only ketamine-related treatment with full FDA approval, specifically for treatment-resistant depression, and it works differently in practice: it's a nasal spray given under a Risk Evaluation and Mitigation Strategy (REMS) inside a certified healthcare setting, not a take-home prescription, so it sits outside this take-home telehealth debate. Our esketamine coverage walks through how that pathway differs.
This is educational information, not medical advice. Ask any prescriber directly which flexibility or exception they rely on, and talk with a licensed clinician about whether ketamine fits your situation before you start treatment. Rules also vary by state; check your state's current posture at state regulations before you assume federal flexibility is the only hurdle.
What to Verify Before You Book
- Ask which specific DEA telehealth flexibility the clinic currently relies on for new patients
- Confirm the prescriber holds an active state medical license and current DEA registration
- Ask what happens to your prescription if the flexibility expires before a visit renewal
- Check whether your state adds telehealth prescribing rules beyond the federal baseline
- Confirm the follow-up and monitoring schedule tied to your ketamine prescription
Before you commit to any provider, it helps to know how to confirm credentials on your own rather than taking a clinic's word for it. Our guide on how to verify a ketamine doctor's license before booking walks through the state license lookups you can run yourself, and our at-home ketamine safety checklist covers what should happen after the prescription is written. If you're still deciding whether telehealth ketamine is a fit at all, start with how to get a ketamine prescription online and plan for ongoing care using ketamine telehealth follow-up care.
Compare Vetted Ketamine Telehealth Providers
See how online ketamine clinics compare on screening quality, prescriber credentials, and follow-up care before you choose one.
Frequently Asked Questions
It can be, when a DEA-registered prescriber is operating under a currently valid federal telehealth flexibility and your state allows it. Legality depends on the specific flexibility in effect at the time, not on a permanent special registration, which still doesn't exist. Verify the current expiration date before assuming continuity.
Special Registration would be a permanent rule Congress ordered in 2018. The flexibility in use today is a temporary, repeatedly extended rule tied originally to the COVID-19 public health emergency. One is a finished regulation; the other is a stopgap that can expire or change.
No. Esketamine is administered in person at a certified healthcare setting under its FDA-required Risk Evaluation and Mitigation Strategy, so it is not a take-home telehealth prescription and isn't affected by this debate the same way generic ketamine is.
If no new extension or final rule takes effect, new patients would generally need an in-person medical evaluation before a controlled-substance prescription under the Ryan Haight Act's baseline rule, though some exceptions, such as DEA-registered facilities, could still apply. Existing patient arrangements may be affected differently depending on how the DEA structures any transition.
Share
Related Reading
Have a question about this topic?
Use the contact page when you need to send feedback, request a correction, or ask about the resource.